Latest Breaking News On - கௌஷள் சோலங்கி - Page 1 : comparemela.com

Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy Font : A-A+ LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, today announced that it has completed a financing round of US$6.2 million led by AXA IM, through AXA IM Alts, a global leader in alternative investments with c. €162 billion of assets under management 1. Eyenuk’s existing investors also participated in the round. Eyenuk will use the proceeds to immediately accelerate commercialization of the EyeArt

United statesZina affas besseFrank chengAsia pacificAffas besseKaushal solankiGlobal health investment fundPartner at global health investment advisorsUs national institutes of healthHealth insurance portabilityUk national health serviceGlobal health investment advisorsEuropean unionEyenuk incHealth canadaManaging partner